Unnatural killer cells to prevent bloodborne metastasis: Inspiration from biology and engineering

Expert Review of Anticancer Therapy

Volumn 14, Issue 6, 2014, Pages 641-644

  Mitchell, Michael J ^a   King, Michael R ^a  

^a School of Operations Research and Industrial Engineering   (United States)

Author keywords

circulating tumor cells; E selectin; leukocyte; TRAIL

Indexed keywords

ANTINEOPLASTIC AGENT; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1 TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND CONJUGATE; UNCLASSIFIED DRUG; DEATH RECEPTOR; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; LIPOSOME; NANOMATERIAL; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; BLOODBORNE METASTASIS; CHEMICAL ENGINEERING; CIRCULATING TUMOR CELL; DRUG CONJUGATION; FLUIDIZED BED REACTOR; HUMAN; KILLER CELL; LUNG METASTASIS; METASTASIS; NONHUMAN; REVIEW; TUMOR CELL DESTRUCTION; UNNATURAL KILLER CELL; ANIMAL; BLOOD RHEOLOGY; CELL ADHESION; CYTOTOXICITY; DRUG EFFECTS; ERYTHROCYTE; IMMUNOLOGY; LEUKOCYTE; METABOLISM; MOUSE; NEOPLASM METASTASIS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TUMOR EMBOLISM;

ANIMALS; APOPTOSIS; CELL ADHESION; CYTOTOXICITY, IMMUNOLOGIC; E-SELECTIN; ERYTHROCYTES; HEMORHEOLOGY; HUMANS; LEUKOCYTES; LIPOSOMES; MICE; NANOSTRUCTURES; NEOPLASM METASTASIS; NEOPLASTIC CELLS, CIRCULATING; RECEPTORS, DEATH DOMAIN; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 84901420521     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/14737140.2014.916619     Document Type: Review

References (20)

1. Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science 2011;331: 1559-64
2. Mitchell MJ, King MR. Computational and experimental models of cancer cell response to fluid shear stress. Front Oncol 2013;3: 1-11
3. Mitchell MJ, King MR. Fluid shear stress sensitizes cancer cells to receptor-mediated apoptosis via trimeric death receptors. New J Phys 2013;15(1):015008
4. Fidler I. The pathogenesis of cancer metastasis: The "seed and soil" hypothesis revisited. Nat Rev Cancer 2003;3:1-6
5. Springer TA. Adhesion receptors of the immune system. Nature 1990;346:425-34
6. McDonald B, Spicer J, Giannais B, et al. Systemic inflammation increases cancer cell adhesion to hepatic sinusoids by neutrophil mediated mechanisms. Int J Cancer 2009;125:1298-305
7. Köhler S, Ullrich S, Richter U, Schumacher U. E-/P-selectins and colon carcinoma metastasis: First in vivo evidence for their crucial role in a clinically relevant model of spontaneous metastasis formation in the lung. Br J Cancer 2010;102(3):602-9
8. Rahn JJ, Chow JW, Horne GJ, et al. MUC1 mediates transendothelial migration in vitro by ligating endothelial cell ICAM-1. Clin Exp Metastasis 2005;22(6):475-83
9. Mitchell MJ, Chen CS, Ponmudi V, et al. E-selectin liposomal and nanotube-targeted delivery of doxorubicin to circulating tumor cells. J Control Release 2012;160:609-17
10. Mitchell MJ, Castellanos CA, King MR. Nanostructured surfaces to target and kill circulating tumor cells while repelling leukocytes. J Nanomater 2012;2012(3):1-10
11. Rana K, Reinhart-King CA, King MR. Inducing apoptosis in rolling cancer cells: A combined therapy with aspirin and immobilized TRAIL and E-selectin. Mol Pharm 2012;9:2219-27
12. Goldsmith HL, Spain S. Margination of leukocytes in blood flow through small tubes. Microvasc Res 1984;27(2):204-22
13. Mitchell MJ, Wayne E, Rana K, et al. TRAIL-coated leukocytes that kill cancer cells in the circulation. Proc Natl Acad Sci USA 2014;111(3):930-5
14. Zhang XD, Nguyen T, Thomas WD, et al. Mechanisms of resistance of normal cells to TRAIL induced apoptosis vary between different cell types. FEBS Lett 2000;482(3): 193-9
15. Perry RH, Green DW. Perry's Chemical Engineers Handbook. 8th edition. McGraw Hill; New York: 1984
16. Mitchell MJ, King MR. Theme: Physical biology in cancer. 3. The role of cell glycocalyx in vascular transport of circulating tumor cells. Am J Physiol Cell Physiol 2014;306:C89-97
17. Xiang H, Nguyen CB, Kelley SK, et al. Tissue distribution, stability, and pharmacokinetics of Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand in human colon carcinoma COLO205 tumor-bearing nude mice. Drug Metab Dispos 2004;32(11):1230-8
18. Tucci P, Agostini M, Grespi F, et al. Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer. Proc Natl Acad Sci USA 2012;109(38):15312-17
19. Herbst RS, Eckhardt SG, Kurzrock R, et al. Phase I dose-escalation study of recombinant human Apo2L/TRAIL, a dual proapoptotic receptor agonist, in patients with advanced cancer. J Clin Oncol 2010;17:2839-46
20. Deeb D, Jiang H, Gao X, et al. Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-kappaB through suppression of IkappaBalpha phosphorylation. Mol Cancer Ther 2004;3(7):803-12